Maidenhead, United Kingdom

Michael G Wyllie


Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 43(Granted Patents)


Location History:

  • Maidenhead, GB (1983 - 1984)
  • Canterbury, GB (1987 - 1993)

Company Filing History:


Years Active: 1983-1993

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael G Wyllie: Innovations in Pharmaceutical Treatments

Introduction

Michael G Wyllie is an accomplished inventor based in Maidenhead, GB, known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has developed innovative methods aimed at treating medical conditions effecting many lives.

Latest Patents

Among his latest patents, Wyllie's notable inventions include a method of treating impotence and a method for the prevention of hypertension. The method for treating impotence focuses on providing relief from erectile impotence in males by administering a specified amount of compounds such as U.K. 52,046, Amlodipine, and Doxazosin. Similarly, his method for preventing hypertension addresses the developmental risks in individuals with elevated natriuretic hormone levels, proposing the use of indoramin or its acceptable salts to effectively lower these hormone levels.

Career Highlights

Throughout his career, Michael G Wyllie has held key positions in reputable companies such as John Wyeth & Brother Limited and Pfizer Corporation. His experiences in these organizations have significantly shaped his innovative approaches and led to the development of his patents.

Collaborations

Wyllie has collaborated with notable professionals in the field, including George M Milne, Jr. and Alan C White. These partnerships have fostered an environment of creativity and innovation, contributing to the success of his inventions.

Conclusion

In conclusion, Michael G Wyllie's work exemplifies the impact that dedicated inventors can have on healthcare. His patents not only advance medical technology but also offer hope to individuals facing health challenges, underscoring the importance of continuous innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…